The combination of KL-6 with HRCT scoring enhances diagnostic accuracy, underscoring its potential clinical utility as a noninvasive biomarker for early detection and monitoring of IPF. The gene discussed is MUC1; the disease is idiopathic pulmonary fibrosis.